{
    "title": "Biogen delays Alzheimer's drug filing plans, shares fall 11%",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-8245037/Biogen-delays-Alzheimers-drug-filing-plans-shares-fall.html",
    "date": "2020-04-22",
    "keywords": [
        "company",
        "drug",
        "filing",
        "roy",
        "time",
        "data",
        "quarter",
        "year",
        "treatment",
        "fda",
        "meeting",
        "biogen",
        "spinraza",
        "covid19",
        "share",
        "inc",
        "approval",
        "submission",
        "morning",
        "trading",
        "application",
        "part",
        "face",
        "officer",
        "michel",
        "vounatsos",
        "quality",
        "mind",
        "dataset",
        "chance",
        "success",
        "decision",
        "analysis",
        "period",
        "food",
        "administration",
        "process",
        "call",
        "summer",
        "change",
        "story",
        "place",
        "analyst",
        "coronavirus",
        "outbreak",
        "virus",
        "boston",
        "team",
        "covid",
        "head",
        "rampd",
        "sandrock",
        "firstquarter",
        "profit",
        "demand",
        "atrophy",
        "sclerosis",
        "impact",
        "pandemic",
        "healthcare",
        "provider",
        "michael",
        "levesque",
        "vice",
        "president",
        "moodys",
        "refinitiv",
        "revenue",
        "reporting",
        "trisha",
        "manas",
        "mishra",
        "bengaluru",
        "editing",
        "anil",
        "dsilva"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}